12 Month Price Forecast For NARI
Distance to NARI Price Forecasts
NARI Price Momentum
🤔 Considering Inari Medical (NARI)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 23, 2025 10:53 AM UTC
NARI Analyst Ratings & Price Targets
Based on our analysis of 17 Wall Street analysts, NARI has a consensus that is neutral. The median price target is $80.00, with forecasts ranging from $50.00 to $80.00. Currently, there are 1 Buy ratings, 13 Hold ratings, and 0 Sell ratings.
With NARI currently trading at $79.42, the median price forecast suggests a 0.7% upside. The most optimistic forecast comes from Adam Maeder at Piper Sandler, projecting a 0.7% upside, while Richard Newitter at Truist Securities provides the most conservative target, suggesting a -37.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NARI Analyst Consensus
NARI Price Target Range
Latest NARI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NARI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 8, 2025 | BTIG | Marie Thibault | Neutral | Downgrade | $0.00 |
| Jan 7, 2025 | William Blair | Margaret Andrew | Market Perform | Downgrade | $0.00 |
| Jan 7, 2025 | Piper Sandler | Adam Maeder | Neutral | Maintains | $80.00 |
| Jan 7, 2025 | Baird | David Rescott | Neutral | Downgrade | $80.00 |
| Jan 7, 2025 | Wells Fargo | Larry Biegelsen | Equal-Weight | Downgrade | $80.00 |
| Jan 7, 2025 | Canaccord Genuity | William Plovanic | Hold | Downgrade | $80.00 |
| Dec 18, 2024 | Truist Securities | Richard Newitter | Hold | Maintains | $63.00 |
| Dec 17, 2024 | Oppenheimer | Steve Lichtman | Outperform | Initiates | $75.00 |
| Oct 30, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Oct 29, 2024 | Canaccord Genuity | William Plovanic | Buy | Maintains | $74.00 |
| Oct 29, 2024 | Piper Sandler | Adam Maeder | Neutral | Maintains | $52.00 |
| Oct 29, 2024 | Baird | David Rescott | Outperform | Maintains | $67.00 |
| Oct 29, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Oct 29, 2024 | Truist Securities | Richard Newitter | Hold | Maintains | $50.00 |
| Oct 14, 2024 | Truist Securities | Richard Newitter | Hold | Maintains | $46.00 |
| Oct 9, 2024 | Needham | Mike Matson | Hold | Reiterates | $0.00 |
| Sep 17, 2024 | Stifel | Mathew Blackman | Hold | Initiates | $50.00 |
| Sep 3, 2024 | Leerink Partners | Mike Kratky | Market Perform | Initiates | $47.00 |
| Aug 26, 2024 | Piper Sandler | Adam Maeder | Neutral | Maintains | $50.00 |
| Aug 9, 2024 | Deutsche Bank | Pito Chickering | Buy | Initiates | $68.00 |
Stocks Similar to Inari Medical Inc
The following stocks are similar to Inari Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Inari Medical Inc (NARI) Financial Data
Inari Medical Inc has a market capitalization of $4.65B with a P/E ratio of -2,647.3x. The company generates $574.50M in trailing twelve-month revenue with a -13.7% profit margin.
Revenue growth is +21.4% quarter-over-quarter, while maintaining an operating margin of -4.3% and return on equity of -17.7%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Inari Medical Inc (NARI) Company Overview
About Inari Medical Inc
Develops innovative catheter-based thrombectomy devices.
Inari Medical, Inc. generates revenue by designing and selling minimally invasive thrombectomy devices and accessories aimed at treating various thromboembolic conditions. Its products are marketed to healthcare professionals such as interventional radiologists, cardiologists, and vascular surgeons, who utilize these devices in clinical procedures to remove blood clots from patients.
Founded in 2011 and headquartered in Irvine, California, Inari Medical has established itself in the medical device industry. The company's products address critical health challenges like deep vein thrombosis, pulmonary embolism, and chronic limb-threatening ischemia, positioning it as a key player in the evolving landscape of interventional medicine.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
1,300
CEO
Mr. Andrew J. Hykes
Country
United States
IPO Year
2020
Website
www.inarimedical.comInari Medical Inc (NARI) Latest News & Analysis
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for Inari Medical, Inc. (NASDAQ:NARI) investors who purchased shares before March 10, 2021.
The investigation into Inari Medical may signal potential legal issues or financial irregularities, impacting stock performance and investor sentiment.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims for investors of Inari Medical, Inc. (NASDAQ:NARI) who purchased shares before March 10, 2021.
The investigation may signal potential legal issues for Inari Medical, which could impact stock performance and investor confidence.
Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice
7 days agoInari Medical, Inc. (NARI) is being evaluated for its potential as a momentum stock pick. Further analysis is needed to determine its suitability for investors.
The inquiry into Inari Medical’s momentum potential signals interest in its growth prospects, which could influence stock demand and market performance.
Bronstein, Gewirtz & Grossman, LLC is investigating claims for investors of Inari Medical, Inc. (NASDAQ:NARI) who purchased shares before March 10, 2021.
The investigation into Inari Medical may indicate potential legal issues or financial misstatements, which could impact the company's stock price and investor confidence.
Bronstein, Gewirtz & Grossman, LLC is investigating claims for Inari Medical, Inc. (NASDAQ:NARI) investors who bought shares before March 10, 2021. Interested parties can visit bgandg.com/NARI for details.
The investigation into Inari Medical may signal potential legal issues or financial irregularities, affecting stock performance and investor confidence.
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
16 days agoStryker is in advanced negotiations to acquire Inari Medical, a company specializing in devices for treating venous diseases, according to sources.
Stryker's potential acquisition of Inari Medical could enhance its product portfolio and market share in the lucrative venous disease treatment sector, impacting future revenue growth and stock performance.
Frequently Asked Questions About NARI Stock
What is Inari Medical Inc's (NARI) stock forecast for 2025?
Based on our analysis of 17 Wall Street analysts, Inari Medical Inc (NARI) has a median price target of $80.00. The highest price target is $80.00 and the lowest is $50.00.
Is NARI stock a good investment in 2025?
According to current analyst ratings, NARI has 1 Buy ratings, 13 Hold ratings, and 0 Sell ratings. The stock is currently trading at $79.42. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for NARI stock?
Wall Street analysts predict NARI stock could reach $80.00 in the next 12 months. This represents a 0.7% increase from the current price of $79.42. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Inari Medical Inc's business model?
Inari Medical, Inc. generates revenue by designing and selling minimally invasive thrombectomy devices and accessories aimed at treating various thromboembolic conditions. Its products are marketed to healthcare professionals such as interventional radiologists, cardiologists, and vascular surgeons, who utilize these devices in clinical procedures to remove blood clots from patients.
What is the highest forecasted price for NARI Inari Medical Inc?
The highest price target for NARI is $80.00 from Adam Maeder at Piper Sandler, which represents a 0.7% increase from the current price of $79.42.
What is the lowest forecasted price for NARI Inari Medical Inc?
The lowest price target for NARI is $50.00 from Richard Newitter at Truist Securities, which represents a -37.0% decrease from the current price of $79.42.
What is the overall NARI consensus from analysts for Inari Medical Inc?
The overall analyst consensus for NARI is neutral. Out of 17 Wall Street analysts, 1 rate it as Buy, 13 as Hold, and 0 as Sell, with a median price target of $80.00.
How accurate are NARI stock price projections?
Stock price projections, including those for Inari Medical Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
